Syk inhibitors in clinical development for hematological malignancies
نویسندگان
چکیده
Spleen tyrosine kinase (Syk) is a cytosolic non-receptor protein tyrosine kinase (PTK) and is mainly expressed in hematopoietic cells. Syk was recognized as a critical element in the B-cell receptor signaling pathway. Syk is also a key component in signal transduction from other immune receptors like Fc receptors and adhesion receptors. Several oral Syk inhibitors including fostamatinib (R788), entospletinib (GS-9973), cerdulatinib (PRT062070), and TAK-659 are being assessed in clinical trials. The second generation compound, entospletinib, showed promising results in clinical trials against B-cell malignancies, mainly chronic lymphoid leukemia. Syk inhibitors are being evaluated in combination regimens in multiple malignancies.
منابع مشابه
HDAC Inhibitors and Heat Shock Proteins (Hsps)
Epigenetic alterations, including DNA acetylation, hypermethylation and hypomethylation, and the associated transcriptional changes of the affected genes are central to the evolution and progression of various human cancers, including pancreatic cancer. Cancer-associated epigenetic alterations are attractive therapeutic targets because such epigenetic alterations, unlike genetic changes, are po...
متن کاملRegular Article CLINICAL TRIALS AND OBSERVATIONS An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia
Spleen tyrosine kinase (Syk) is a cytoplasmic protein tyrosine kinase that is predominantly expressed in cells of hematopoietic lineage. Syk functions normally to couple activated immunoreceptors to downstream signaling pathways. Syk signaling elicits a range of diverse biologic functions, including cellular development, function, proliferation, differentiation, and adhesion. In a normal, resti...
متن کاملDetermination of Serologic and Molecular Prevalence of Hepatitis Type B, C, and G Infections in Patients with Hematological Malignancy in the South of Fars Province, Iran
Background & Objectives: Hepatitis type G virus (HGV) is a flavivirus with RNA genome which has high nucleotide and amino acid similarity with HCV. HGV can infect blood lymphocytes for long period and may have role in inducing or complicating the clinical outcomes in patients with hematological malignancies. Therefore in this study the prevalence of HGV, HCV, and HBV infections were evaluated i...
متن کاملB-cell kinase inhibitors in rheumatoid arthritis
Introduction The pathogenesis of rheumatoid arthritis (RA) involves systemic dysregulation of T and B lymphocytes resulting in immune responses against self-antigens, and ultimately leading to downstream effects such as cartilage destruction, pannus formation, and bone erosion. Clinical evidence for the role of B cells in RA includes the effectiveness of rituximab, an antibody designed to deple...
متن کاملVIII. New markers in peripheral T-cell lymphomas: more entities or more confusion?
Peripheral T-cell lymphomas (PTCLs) are heterogeneous and uncommon malignancies featuring an aggressive clinical course and a mostly poor outcome with current treatment strategies [1]. Recent developments using genome-wide molecular profiling methods have provided novel insights into their pathobiology and identified new markers with diagnostic, prognostic and/or therapeutic implications.Cell l...
متن کامل